MOUD

Webinar Reflection: Integrated Care for Syndemics, Bringing SUD, HIV & HCV Treatment Together

ISSUP hosted a webinar on 4 December 2025 with Dr Sarah Kattakuzhy, exploring integrated care for the syndemic of SUD, HIV, and HCV. She highlighted that these conditions often occur together and intensify one another, making siloed approaches ineffective. The session showcased strong evidence that integrated care models; whether co-located, mobile, telemedicine-supported, or provider-integrated; improve uptake, viral suppression, and HCV cure rates. Case studies illustrated how person-centred, joined-up care strengthens trust, stability, and quality of life. The discussion emphasized the significant opportunity to scale integrated, flexible, and humane care models across diverse health systems.

Barriers and facilitators to scaling up medications for opioid use disorder in Kentucky: qualitative perspectives of treatment organisation staff

Scientific article

2 April 2025

Background Many people who could benefit from medications for opioid use disorder (MOUD) aren’t receiving them. This study looks at how MOUD agencies in Kentucky are experiencing changes in patient numbers and the challenges and supports...

Trauma exposure across the lifespan among individuals engaged in treatment with medication for opioid use disorder: differences by gender, PTSD status, and chronic pain

Scientific article

3 May 2024

Background There is little research on lifetime trauma exposure among individuals undergoing medication treatment for opioid use disorder (MOUD). A multisite study examined the prevalence of lifetime trauma and explored differences based on...

Trauma exposure across the lifespan among individuals engaged in treatment with medication for opioid use disorder: differences by gender, PTSD status, and chronic pain

Scientific article

3 May 2024

Background: Limited research has been conducted on lifetime trauma exposure among individuals undergoing medication treatment for opioid use disorder (MOUD). A multisite study provided an opportunity to investigate the prevalence of...

Trauma exposure across the lifespan among individuals engaged in treatment with medication for opioid use disorder: differences by gender, PTSD status, and chronic pain

Scientific article

3 May 2024

There is little study of lifetime trauma exposure among individuals engaged in medication treatment for opioid use disorder (MOUD). A multisite study provided the opportunity to examine the prevalence of lifetime trauma and differences by gender, PTSD status, and chronic pain.

Integrating Opioid Use Disorder Treatment Into Primary Care Settings

Scientific article

11 August 2023

Abstract Importance Medication for opioid use disorder (MOUD) (eg, buprenorphine and naltrexone) can be offered in primary care, but barriers to implementation exist. Objective To evaluate an implementation intervention over 2 years to...

Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021

Scientific article

7 August 2023

Discussion Despite guidelines recommending MOUD, approximately 1 in 5 adults with past-year OUD received any MOUD. Furthermore, some groups were substantially less likely to receive MOUD, in particular Black adults, women, those unemployed...